País: Israel
Idioma: anglès
Font: Ministry of Health
CEFTRIAXONE AS SODIUM
A.L. MEDI-MARKET LTD.
J01DD04
POWDER FOR SOLUTION FOR INJ/INF
CEFTRIAXONE AS SODIUM 1 G/VIAL
I.M, I.V
Required
MEDOCHEMIE LTD (FACTORY C), CYPRUS
CEFTRIAXONE
Ceftriaxone is indicated for the treatment of the following infections in adults and children including term neonates (from birth): Bacterial Meningitis Community acquired pneumonia Hospital acquired pneumonia Acute otitis media Intra-abdominal infections Complicated urinary tract infections (including pyelonephritis) Infections of bones and joints Complicated skin and soft tissue infections Gonorrhoea Syphilis Bacterial endocarditisCeftriaxone may be used: For treatment of acute exacerbations of chronic obstructive pulmonary disease in adults For treatment of disseminated Lyme borreliosis (early (stage II) and late (stage III) in adults and children including neonates from 15 days of age. For pre-operative prophylaxis of surgical site infections In the management of neutropenic patients with fever that is suspected to be due to a ceftriaxone – susceptible bacterial infection In the treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed aboveCeftriaxone should be co-administered with other antibacterial agents whenever the possible range of causative bacteria would not fall within its spectrum.Consideration should be given to official guidelines on the appropriate use of antibacterial agents.
2021-03-17
Page 1 of 18 CEFTRIAXONE MEDO 1 GR Powder for solution for injection/infusion 1. Name of the medicinal product CEFTRIAXONE MEDO 1 GR Powder for solution for injection/infusion 2. Qualitative and quantitative composition Each vial of Ceftriaxone Medo 1 Gr contains 1 gr ceftriaxone as ceftriaxone sodium Excipient with known effect: Sodium 1g vial contains 3.6 mmol (or 83 mg) of sodium per vial. For a full list of excipients, see section 6.1. 3. Pharmaceutical form Powder for solution for injection/infusion. Almost white or yellowish crystalline powder, slightly hygroscopic. 4. Clinical particulars 4.1 Therapeutic Indications Ceftriaxone Medo 1 Gr is indicated for the treatment of the following infections in adults and children including term neonates (from birth): - Bacterial Meningitis - Community acquired pneumonia - Hospital acquired pneumonia - Acute otitis media - Intra-abdominal infections - Complicated urinary tract infections (including pyelonephritis) - Infections of bones and joints - Complicated skin and soft tissue infections - Gonorrhoea - Syphilis - Bacterial endocarditis Ceftriaxone MEDO 1 GR may be used: - For treatment of acute exacerbations of chronic obstructive pulmonary disease in adults. - For treatment of disseminated Lyme borreliosis (early (stage II) and late (stage III) in adults and children including neonates from 15 days of age. - For pre-operative prophylaxis of surgical site infections. - In the management of neutropenic patients with fever that is suspected to be due to a ceftriaxone-susceptible bacterial infection. - In the treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. Page 2 of 18 Ceftriaxone Medo 1 Gr should be co-administered with other antibacterial agents whenever the possible range of causative bacteria would not fall within its spectrum (see section 4.4). Consideration should be given to official guidelines on the appropriate use of antibacterial agents. 4.2 Posology and metho Llegiu el document complet